BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1278 related articles for article (PubMed ID: 18685286)

  • 1. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies.
    Hantson P; Kevers L; Fabien N; Van Den Bergh P
    Muscle Nerve; 2010 Mar; 41(3):423-6. PubMed ID: 19918775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.
    Ruts L; van Koningsveld R; van Doorn PA
    Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
    Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
    No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.
    Mori K; Hattori N; Sugiura M; Koike H; Misu K; Ichimura M; Hirayama M; Sobue G
    Neurology; 2002 Mar; 58(6):979-82. PubMed ID: 11914423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehabilitation of a marathon runner with Guillain-Barré syndrome.
    Fisher TB; Stevens JE
    J Neurol Phys Ther; 2008 Dec; 32(4):203-9. PubMed ID: 19265762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 13. Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy.
    Oh SJ; LaGanke C; Powers R; Wolfe GI; Quinton RA; Burns DK
    Neurology; 2005 Nov; 65(10):1639-42. PubMed ID: 16301495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP.
    Comi C; Osio M; Ferretti M; Mesturini R; Cappellano G; Chiocchetti A; Carecchio M; Nascimbene C; Varrasi C; Cantello R; Mariani C; Monaco F; Dianzani U
    J Peripher Nerv Syst; 2009 Jun; 14(2):101-6. PubMed ID: 19691532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
    Muley SA; Kelkar P; Parry GJ
    Arch Neurol; 2008 Nov; 65(11):1460-4. PubMed ID: 19001164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.